VENTANA anti-Her2/neu (4B5) Rabbit Monoclonal Primary Antibody
VENTANA anti-HER2/neu (4B5) is intended for the semi-quantitative detection of HER2 antigen in sections of formalin-fixed, paraffin-embedded normal and neoplastic breast and gastric tissue on a VENTANA automated IHC/ISH slide staining device. It is indicated as an aid in the assessment of breast and gastric cancer patients for whom Herceptin treatment is considered and for breast cancer patients for whom Kadcyla (trastuzumab emtansine) or Perjeta (pertuzumab) treatments are being considered. Please note that Kadcyla and Perjeta are not approved for use in all geographies. This product should be interpreted by a qualified pathologist in conjunction with histological examination, relevant clinical information, and proper controls. This antibody is intended for in vitro diagnostic use.